The use of molecular markers to predict for optimal cytoreduction in ovarian cancer

被引：0
|
作者：
Fuh, K. [1 ]
Kiet, T. [1 ]
Chen, L. [1 ]
Sherman, A. [1 ]
Kapp, D. [2 ]
Chan, J. [1 ]
机构：
[1] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [31] Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer
    Spagnol, Giulia
    Bigardi, Sofia
    Zorzi, Michela
    Morotti, Matteo
    Carollo, Massimo
    Bruni, Giulia Micol
    De Tommasi, Orazio
    Tamagnini, Matteo
    Xhindoli, Livia
    Noventa, Marco
    Tozzi, Roberto
    Saccardi, Carlo
    Marchetti, Matteo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [32] Cytoreduction for advanced ovarian cancer in perspective
    Hacker, NF
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (02) : 159 - 160
  • [33] Secondary cytoreduction for recurrent ovarian cancer
    Park, SY
    PROCEEDINGS OF THE XIX ASIAN AND OCEANIC CONGRESS OF OBSTETRICS & GYNECOLOGY, 2005, : 127 - 135
  • [34] Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?
    Angioli, Roberto
    Plotti, Francesco
    Capriglione, Stella
    Aloisi, Alessia
    Montera, Roberto
    Luvero, Daniela
    Miranda, Andrea
    Cafa, Ester Valentina
    Damiani, Patrizio
    Benedetti-Panici, Pierluigi
    GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 579 - 583
  • [35] FDG PET/CT parameters and CA-125 levels to predict optimal cytoreduction at primary cytoreductive surgery for advanced ovarian cancer
    Kim, Junhwan
    Lee, Maria
    Kim, Se Ik
    Gil, Joonhyung
    Kim, Jae-Weon
    Cheon, Gi Jeong
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S91 - S91
  • [36] Secondary cytoreduction for relapsed ovarian cancer
    Garg, Pankaj Kumar
    Kumar, Rahul
    Choudhary, Deepti
    LANCET ONCOLOGY, 2021, 22 (06): : E230 - E230
  • [37] A Proteomics Panel for Predicting Optimal Primary Cytoreduction in Stage III/IV Ovarian Cancer
    Risum, Signe
    Hogdall, Estrid
    Engelholm, Svend A.
    Fung, Eric
    Lomas, Lee
    Yip, Christine
    Petri, Anette L.
    Nedergaard, Lotte
    Lundvall, Lene
    Hogdall, Claus
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (09) : 1535 - 1538
  • [38] Concept of optimal surgical cytoreduction in advanced ovarian cancer: A brief critique and a call for action
    Markman, Maurie
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4168 - 4170
  • [39] Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis
    Keskin, Serkan
    Kucucuk, Seden
    Ak, Naziye
    Atalar, Banu
    Sari, Murat
    Sozen, Hamdullah
    Ibis, Kamuran
    Topuz, Samet
    Saip, Pinar
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 101 - 105
  • [40] Evaluation of prognostic factors for advanced ovarian cancer treatment with an emphasis on optimal primary cytoreduction
    Vrhkar, Natasa
    Vakselj, Ales
    Verdenik, Ivan
    Smrkolj, Spela
    Barbic, Matija
    Cvjeticanin, Branko
    Meglic, Leon
    Kobal, Borut
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (7-8): : 509 - 516
12345